Yıl: 2022 Cilt: 54 Sayı: 3 Sayfa Aralığı: 242 - 247 Metin Dili: İngilizce DOI: 10.5152/eurasianjmed.2022.22031 İndeks Tarihi: 06-05-2023

The Effects of Laboratory Parameters on the Prognosis of COVID-19

Öz:
Objective: While the coronavirus disease 2019 pandemic is an ongoing issue across the world, understand- ing the course of the disease is important for early diagnosis and treatment. We aimed, with this study, to determine the differences between laboratory parameters in different clinical pictures of coronavirus disease 2019. Materials and Methods: The study included 443 patients who presented to Atatürk University Medical Faculty Hospital between March 15, 2020, and June 15, 2020, and were diagnosed with coronavirus disease 2019 upon a positive Real Time Polymerase Chain Reaction (RT-PCR) result. The hospitalized patients were divided into 4 groups based on their clinical status. The roles of these markers in determining the severity of coronavirus disease 2019 were statistically evaluated. Results: A total of 443 patients with RT-PCR confirmation were included in the study. The mean age was 46.0 ± 19.1 years and 54.4% of the patients were male. According to the clinical classification, 16.3% of the cases were asymptomatic, 25.7% uncomplicated, 35.7% mild/moderate, and 22.3% severe. The first 3 most frequent symptoms were cough (21.3%), fever (17.7%), and fatigue (15.5%). Hypertension (36.1%) was the major comorbidity among the patients. During the follow-up of severe cases, 39.4% developed the need for intensive care. The overall mortality rate, on the other hand, was 4.7%. Regarding laboratory parameters, procalcitonin (PCT), serum ferritin, erythrocyte sedimentation rate, C-reactive protein, neutrophil count, D-dimer, troponin, and lactate dehydrogenase were at the highest level in the severe patient group while albumin, platelet, and lymphocyte count were found to be at the lowest level in the same group. A statistically significant difference was detected between the groups (P < .001). Conclusion: The increase in C-reactive protein, PCT, erythrocyte sedimentation rate, ferritin, troponin, D-dimer, lactate dehydrogenase, and neutrophil count and the decrease in albumin, platelet, and lymphocyte count are significant in the severe patient group; it has been concluded that they can be used to determine the severity of coronavirus disease 2019.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. WHO: WHO Virtual Press Conference on COVID-19. Accessed 16 March 2020; 2020.
  • 2. Zhang YZ, Holmes EC. A genomic perspective on the origin and emergence of SARS-CoV-2. Cell. 2020;181(2):223-227. [CrossRef]
  • 3. Bilge N, Can FK, Alay H. The relationship of headache with inflammatory serum parameters and disease severity in COVID-19 patients. Duzce Med J. 2020;22(suppl1):44-50.
  • 4. Mehta P, McAuley DF, Brown M, et al. COVID- 19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-1034. [CrossRef]
  • 5. Tay MZ, Poh CM, Rénia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflamma- tion and intervention. Nat Rev Immunol. 2020;20(6):363-374. [CrossRef]
  • 6. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420-422. [CrossRef]
  • 7. Kesmez Can F, Özkurt Z, Öztürk N, Sezen S. Effect of IL-6, IL-8/CXCL8, IP-10/CXCL 10 levels on the severity in COVID 19 infection. Int J Clin Pract. 2021;75(12):e14970. [CrossRef]
  • 8. Chen G, Wu D, Guo W, et al. Clinical and immu- nological features of severe and moderate coro- navirus disease 2019. J Clin Invest. 2020;130(5):2620-2629. [CrossRef]
  • 9. Jose RJ, Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagula- tion. Lancet Respir Med. 2020;8(6):e46-e47. [CrossRef]
  • 10. Tang N, Li D, Wang X, Sun Z. Abnormal coagula- tion parameters are associated with poor prog- nosis in patients with novel coronavirus pneumo- nia. J Thromb Haemost. 2020;18(4):844-847. [CrossRef]
  • 11. Liu Y, Du X, Chen J, et al. Neutrophil -to-lympho cyte ratio as an independent risk factor for mor- tality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6-e12. [CrossRef]
  • 12. Aktas G, Duman TT, Atak BM, et al. Irritable bowel syndrome is associated with novel inflam- matory markers derived from hemogram parameters. fmpcr. 2020;22(2):107-110. [CrossRef]
  • 13. Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and mortality among black patients and white patients with Covid-19. N Engl J Med. 2020;382(26):2534-2543. [CrossRef]
  • 14. Li G, De Clercq E. Therapeutic options for the 2019 novel coronavirus (2019-nCoV). Nat Rev Drug Discov. 2020;19(3):149-150. [CrossRef]
  • 15. Wang M, Zhu Q, Fu J, Liu L, Xiao M, Du Y. Dif- ferences of inflammatory and non-inflammatory indicators in coronavirus disease-19 (COVID- 19) with different severity. Infect Genet Evol. 2020;85:104511. [CrossRef]
  • 16. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497- 506. [CrossRef]
  • 17. Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116(6):1097-1100. [CrossRef]
  • 18. He X, Yao F, Chen J, et al. The poor prognosis and influencing factors of high D-dimer levels for COVID-19 patients. Sci Rep. 2021;11(1):1830. [CrossRef]
  • 19. Ge YL, Liu CH, Wang N, et al. Elevated plasma D-dimer in adult community-acquired pneumo- nia patients is associated with an increased inflammatory reaction and lower survival. Clin Lab. 2019;65(1):10.7754. [CrossRef]
  • 20. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in criti- cally ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147. [CrossRef]
  • 21. Idogun PO, Ward MC, Teklie Y, Wiese-Rom- etsch W, Baker J. Newly diagnosed idiopathic thrombocytopenia post COVID-19 vaccine administration. Cureus. 2021;13(5):e14853. [CrossRef]
  • 22. Asghar MS, Haider Kazmi SJ, Khan NA, et al. Poor prognostic biochemical markers predicting fatalities caused by COVID-19: a retrospective observational study from a developing country. Cureus. 2020;12(8):e9575. [CrossRef]
  • 23. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. [CrossRef]
  • 24. Zeng F, Huang Y, Guo Y, et al. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis. 2020;96:467-474. [CrossRef]
  • 25. Lippi G, Plebani M. Procalcitonin in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chim Acta. 2020;505:190-191. [CrossRef]
  • 26. Bastug A, Bodur H, Erdogan S, et al. Clinical and laboratory features of COVID-19: predictors of severe prognosis. Int Immunopharmacol. 2020;88:106950. [CrossRef]
  • 27. Wu C, Chen X, Cai Y, et al. Risk factors associ- ated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-943. [CrossRef]
  • 28. Frencken JF, van Baal L, Kappen TH, et al. Myo- cardial injury in critically ill patients with commu- nity-acquired pneumonia. A cohort study. Ann Am Thorac Soc. 2019;16(5):606-612. [CrossRef]
  • 29. Méndez R, Menéndez R, Amara-Elori I, et al. Lymphopenic community-acquired pneumonia is associated with a dysregulated immune response and increased severity and mortality. J Infect. 2019;78(6):423-431. [CrossRef]
  • 30. de Wit E, van Doremalen N, Falzarano D, Mun- ster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14(8):523-534. [CrossRef]
  • 31. Shang W, Dong J, Ren Y, et al. The value of clinical parameters in predicting the severity of COVID- 19. J Med Virol. 2020;92(10):2188-2192. [CrossRef]
  • 32. Kowdley KV, Belt P, Wilson LA, et al. Serum fer- ritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease. Hepatology. 2012;55(1):77-85. [CrossRef]
  • 33. Taneri PE, Gómez-Ochoa SA, Llanaj E, et al. Ane- mia and iron metabolism in COVID-19: a sys- tematic review and meta-analysis. Eur J Epidemiol. 2020;35(8):763-773. [CrossRef]
  • 34. Deng F, Zhang L, Lyu L, et al. Increased levels of ferritin on admission predicts intensive care unit mortality in patients with COVID-19. Med Clin. 2021;156(7):324-331. [CrossRef]
  • 35. Bernardi M, Angeli P, Claria J, et al. Albumin in decompensated cirrhosis: new concepts and perspectives. Gut. 2020;69(6):1127-1138. [CrossRef]
  • 36. Li J, Li M, Zheng S, et al. Plasma albumin levels predict risk for nonsurvivors in critically ill patients with COVID-19. Biomark Med. 2020;14(10):827-837. [CrossRef]
  • 37. Liu W, Tao ZW, Wang L, et al. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032-1038. [CrossRef]
  • 38. Henry BM, Aggarwal G, Wong J, et al. Lactate dehydrogenase levels predict coronavirus dis- ease 2019 (COVID-19) severity and mortality: a pooled analysis. Am J Emerg Med. 2020;38(9):1722- 1726. [CrossRef]
APA KESMEZ CAN F, Alay H, Albayrak A, OZDEN K, Yılmaz S, Ozturk N, Ozkurt Z, PARLAK E, Tekin E, kocak a (2022). The Effects of Laboratory Parameters on the Prognosis of COVID-19. , 242 - 247. 10.5152/eurasianjmed.2022.22031
Chicago KESMEZ CAN Fatma,Alay Handan,Albayrak Ayse,OZDEN KEMALETTIN,Yılmaz Sinan,Ozturk Nurinnisa,Ozkurt Zulal,PARLAK EMINE,Tekin Erdal,kocak abdullah osman The Effects of Laboratory Parameters on the Prognosis of COVID-19. (2022): 242 - 247. 10.5152/eurasianjmed.2022.22031
MLA KESMEZ CAN Fatma,Alay Handan,Albayrak Ayse,OZDEN KEMALETTIN,Yılmaz Sinan,Ozturk Nurinnisa,Ozkurt Zulal,PARLAK EMINE,Tekin Erdal,kocak abdullah osman The Effects of Laboratory Parameters on the Prognosis of COVID-19. , 2022, ss.242 - 247. 10.5152/eurasianjmed.2022.22031
AMA KESMEZ CAN F,Alay H,Albayrak A,OZDEN K,Yılmaz S,Ozturk N,Ozkurt Z,PARLAK E,Tekin E,kocak a The Effects of Laboratory Parameters on the Prognosis of COVID-19. . 2022; 242 - 247. 10.5152/eurasianjmed.2022.22031
Vancouver KESMEZ CAN F,Alay H,Albayrak A,OZDEN K,Yılmaz S,Ozturk N,Ozkurt Z,PARLAK E,Tekin E,kocak a The Effects of Laboratory Parameters on the Prognosis of COVID-19. . 2022; 242 - 247. 10.5152/eurasianjmed.2022.22031
IEEE KESMEZ CAN F,Alay H,Albayrak A,OZDEN K,Yılmaz S,Ozturk N,Ozkurt Z,PARLAK E,Tekin E,kocak a "The Effects of Laboratory Parameters on the Prognosis of COVID-19." , ss.242 - 247, 2022. 10.5152/eurasianjmed.2022.22031
ISNAD KESMEZ CAN, Fatma vd. "The Effects of Laboratory Parameters on the Prognosis of COVID-19". (2022), 242-247. https://doi.org/10.5152/eurasianjmed.2022.22031
APA KESMEZ CAN F, Alay H, Albayrak A, OZDEN K, Yılmaz S, Ozturk N, Ozkurt Z, PARLAK E, Tekin E, kocak a (2022). The Effects of Laboratory Parameters on the Prognosis of COVID-19. Eurasian Journal of Medicine, 54(3), 242 - 247. 10.5152/eurasianjmed.2022.22031
Chicago KESMEZ CAN Fatma,Alay Handan,Albayrak Ayse,OZDEN KEMALETTIN,Yılmaz Sinan,Ozturk Nurinnisa,Ozkurt Zulal,PARLAK EMINE,Tekin Erdal,kocak abdullah osman The Effects of Laboratory Parameters on the Prognosis of COVID-19. Eurasian Journal of Medicine 54, no.3 (2022): 242 - 247. 10.5152/eurasianjmed.2022.22031
MLA KESMEZ CAN Fatma,Alay Handan,Albayrak Ayse,OZDEN KEMALETTIN,Yılmaz Sinan,Ozturk Nurinnisa,Ozkurt Zulal,PARLAK EMINE,Tekin Erdal,kocak abdullah osman The Effects of Laboratory Parameters on the Prognosis of COVID-19. Eurasian Journal of Medicine, vol.54, no.3, 2022, ss.242 - 247. 10.5152/eurasianjmed.2022.22031
AMA KESMEZ CAN F,Alay H,Albayrak A,OZDEN K,Yılmaz S,Ozturk N,Ozkurt Z,PARLAK E,Tekin E,kocak a The Effects of Laboratory Parameters on the Prognosis of COVID-19. Eurasian Journal of Medicine. 2022; 54(3): 242 - 247. 10.5152/eurasianjmed.2022.22031
Vancouver KESMEZ CAN F,Alay H,Albayrak A,OZDEN K,Yılmaz S,Ozturk N,Ozkurt Z,PARLAK E,Tekin E,kocak a The Effects of Laboratory Parameters on the Prognosis of COVID-19. Eurasian Journal of Medicine. 2022; 54(3): 242 - 247. 10.5152/eurasianjmed.2022.22031
IEEE KESMEZ CAN F,Alay H,Albayrak A,OZDEN K,Yılmaz S,Ozturk N,Ozkurt Z,PARLAK E,Tekin E,kocak a "The Effects of Laboratory Parameters on the Prognosis of COVID-19." Eurasian Journal of Medicine, 54, ss.242 - 247, 2022. 10.5152/eurasianjmed.2022.22031
ISNAD KESMEZ CAN, Fatma vd. "The Effects of Laboratory Parameters on the Prognosis of COVID-19". Eurasian Journal of Medicine 54/3 (2022), 242-247. https://doi.org/10.5152/eurasianjmed.2022.22031